Age-related macular degeneration (AMD) is a neurodegenerative disease of the aging retina, in which patients experience severe vision loss. AMD is one of the most prevalent ocular conditions in developed countries with more than 10 million US adults affected by AMD. Based on severity of the disease, It is of three stages: Early, Intermediate and Late-stage; Late stage AMD is of two types: Dry AMD and Neovascular AMD (nAMD).
AMD’s progression leads to loss of central vision, leaving many patients unable to read, write, or recognize both color and detail, thus compromising the quality of life. Although AMD’s exact functional pathogenesis is not fully understood, there have been recent improvements in genetic technologies leading to the identification of various polymorphisms that have shown to harbor unique associations with AMD. This has led to identification of many new targets for controlling disease progression.
DelveInsight’s “Age Related Macular Degeneration Market Insights, Epidemiology, and Market Forecast-2032″ report delivers an in-depth understanding of the Age Related Macular Degeneration, historical and forecasted epidemiology as well as the Age Related Macular Degeneration market trends in the United States, EU5 (Germany, Spain, Italy, France, and United Kingdom) and Japan.
Some facts of Age-related macular degeneration (AMD) Market Report
Scope of the Age-related macular degeneration (AMD) Market Report
Click here to Request for Age Related Macular Degeneration Market Sample Page: https://www.delveinsight.com/report-store/age-related-macular-degeneration-market
Age-related macular degeneration (AMD) Companies are:
To get detailed insights into Age-related macular degeneration Pipeline therapies and companies working in the domain, Click here: https://www.delveinsight.com/sample-request/age-related-macular-degeneration-market
Age-related macular degeneration (AMD) Pipeline Drugs and Therapies:
To get competitive insights into Age-related macular degeneration Pipeline, Click here: https://www.delveinsight.com/sample-request/age-related-macular-degeneration-market
Table of Content
1. Key Insights
2. Executive Summary
3. Age-related macular degeneration Competitive Intelligence Analysis
4. Age-related macular degeneration Market Overview at a Glance
5. Age-related macular degeneration Disease Background and Overview
6. Age-related macular degeneration Patient Journey
7. Age-related macular degeneration Epidemiology and Patient Population
8. Age-related macular degeneration Treatment Algorithm, Current Treatment, and Medical Practices
9. Age-related macular degeneration Unmet Needs
10. Key Endpoints of Age-related macular degeneration Treatment
11. Age-related macular degeneration Marketed Products
12. Age-related macular degeneration Emerging Therapies
13. Age-related macular degeneration Seven Major Market Analysis
14. Attribute Analysis
15. Age-related macular degeneration Market Outlook (7 major markets)
16. Age-related macular degeneration Access and Reimbursement Overview
17. KOL Views on the Age-related macular degeneration Market.
18. Age-related macular degeneration Market Drivers
19. Age-related macular degeneration Market Barriers
20. Appendix
21. DelveInsight Capabilities
22. Disclaimer
About DelveInsight
DelveInsight is a leading Business Consultant, and Market Research Firm focused exclusively on life sciences. It supports pharma companies by providing end-to-end comprehensive solutions to improve their performance.
Media ContactCompany Name: DelveInsight Business Research LLPContact Person: Ankit NigamEmail: Send EmailPhone: +19193216187Address:304 S. Jones Blvd #2432 City: AlbanyState: New YorkCountry: United StatesWebsite: https://www.delveinsight.com/report-store/age-related-macular-degeneration-market